Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1.
about
Targeting the Brain Reservoirs: Toward an HIV CureOngoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory AgentsMultiple Histone Lysine Methyltransferases Are Required for the Establishment and Maintenance of HIV-1 Latency.HIV-1 Latency-Reversing Agents Prostratin and Bryostatin-1 Induce Blood-Brain Barrier Disruption/Inflammation and Modulate Leukocyte Adhesion/Transmigration.Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications.Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infectionUltrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.HIV latency is reversed by ACSS2-driven histone crotonylation.Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents.Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins.Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies.BI-2536 and BI-6727, dual Polo-like kinase/bromodomain inhibitors, effectively reactivate latent HIV-1.Novel Latency Reversal Agents for HIV-1 Cure.Total HIV DNA: a global marker of HIV persistence.
P2860
Q28075694-14622CD7-E494-4C58-A057-C1FAD5188E4FQ28079455-89872F74-B300-4405-904C-0FFDDDFD7C45Q37695602-FC92CD66-DB72-44D2-B188-811E57289806Q38725384-1B0ABA6E-ACE3-419C-84A1-EE59251FF41EQ38936786-62F333F3-3FBB-4E60-B210-BC073356A5ADQ38977425-DAF58C4C-7DC9-4F8C-988C-C6137C546307Q40375858-C6416871-463E-43E5-AADD-99E581AF706EQ49851068-26C8CA52-4CF9-42E2-9DCE-ED5FE89CB3EEQ49925023-200F10C6-B940-4BC1-A400-FE09C296F8D2Q50022535-0C1A920B-FB47-4AB8-BA22-2CFADF491A4AQ52431127-44940B30-23D5-417A-B73D-91604378F44DQ52687695-A0CC59B3-1BAD-4AD6-86CC-5B606C10658AQ52816327-3EEE6360-C66F-49E6-A1D0-DE125B6057A0Q54242626-D5FFE836-9CE4-4924-BA99-5F8701B68957
P2860
Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Sequential treatment with 5-az ...... inhibitors reactivates HIV-1.
@ast
Sequential treatment with 5-az ...... inhibitors reactivates HIV-1.
@en
type
label
Sequential treatment with 5-az ...... inhibitors reactivates HIV-1.
@ast
Sequential treatment with 5-az ...... inhibitors reactivates HIV-1.
@en
prefLabel
Sequential treatment with 5-az ...... inhibitors reactivates HIV-1.
@ast
Sequential treatment with 5-az ...... inhibitors reactivates HIV-1.
@en
P2093
P2860
P50
P356
P1476
Sequential treatment with 5-az ...... inhibitors reactivates HIV-1.
@en
P2093
Adeline Melard
Benoit Van Driessche
Caroline Vanhulle
Francis Corazza
Gilles Darcis
Jean-Stéphane Gatot
Kabamba Kabeya
Marion Pardons
Nadège Delacourt
P2860
P304
P356
10.15252/EMMM.201505557
P50
P577
2015-12-17T00:00:00Z